Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors

Abstract

Aberrant activation of the Ras/Raf-1/extracellular-regulated kinase (ERK) pathway has been shown to be involved in the progression of human hepatocellular carcinoma (HCC). However, the mechanism of dysregulation of ERK activation is poorly understood. Recently, we identified Sprouty-related protein with Ena/vasodilator-stimulated phosphoprotein homology-1 domain (Spred) as a physiological inhibitor of the Ras/Raf-1/ERK pathway. In this study, we found that the expression levels of Spred-1 and -2 in human HCC tissue were frequently decreased, comparing with those in adjacent non-tumorous tissue. Moreover, Spred expression levels in HCC tissue were inversely correlated with the incidence of tumor invasion and metastasis. Forced expression of Spred-1 inhibited HCC cell proliferation in vitro and in vivo, which was associated with reduced ERK activation. Spred-1 overexpression also reduced the secretion of matrix metalloproteinase-9 (MMP-9) and MMP-2, which play important roles in tumor invasion and metastasis. In addition, Spred-1 inhibited growth factor-mediated HCC cell motility. These data indicate that the reduction of Spred expression in HCC is one of the causes of the acquisition of malignant features. Thus, Spred could be not only a novel prognostic factor but also a new therapeutic target for human HCC.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Amano M, Fukata Y, Kaibuchi K . (2000). Exp Cell Res 261: 44–51.

  • Bottazzi ME, Zhu X, Bohmer RM, Assoian RK . (1999). J Cell Biol 146: 1255–1264.

  • Chen L, Zeng Y, Yang H, Lee TD, French SW, Corrales FJ et al. (2004). FASEB J 18: 914–916.

  • Coussens LM, Tinkle CL, Hanahan D, Werb Z . (2000). Cell 103: 481–490.

  • Ehrenreiter K, Piazzolla D, Velamoor V, Sobczak I, Small JV, Takeda J et al. (2005). J Cell Biol 168: 955–964.

  • Inoue H, Kato R, Fukuyama S, Nonami A, Taniguchi K, Matsumoto K et al. (2005). J Exp Med 201: 73–82.

  • Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A et al. (1998). Hepatology 27: 951–958.

  • Johnson GL, Lapadat R . (2002). Science 298: 1911–1912.

  • Kato R, Nonami A, Taketomi T, Wakioka T, Kuroiwa A, Matsuda Y et al. (2003). Biochem Biophys Res Commun 302: 767–772.

  • Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E et al. (2001). Hepatology 33: 1087–1097.

  • Liu JF, Crepin M, Liu JM, Barritault D, Ledoux D . (2002). Biochem Biophys Res Commun 293: 1174–1182.

  • Marrero JA, Lok AS . (2004). Gastroenterology 127: S113–S119.

  • Marshall CJ . (1995). Cell 80: 179–185.

  • Masson V, de la Ballina LR, Munaut C, Wielockx B, Jost M, Maillard C et al. (2005). FASEB J 19: 234–236.

  • McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF . (2003). Mol Cell Biol 23: 216–228.

  • Mikula M, Schreiber M, Husak Z, Kucerova L, Ruth J, Wieser R et al. (2001). EMBO J 20: 1952–1962.

  • Miyoshi K, Wakioka T, Nishinakamura H, Kamio M, Yang L, Inoue M et al. (2004). Oncogene 23: 5567–5576.

  • Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM . (2000). J Clin Oncol 18: 1135–1149.

  • Nonami A, Kato R, Taniguchi K, Yoshiga D, Taketomi T, Fukuyama S et al. (2004). J Biol Chem 279: 52543–52551.

  • Potempa S, Ridley AJ . (1998). Mol Biol Cell 9: 2185–2200.

  • Prehoda KE, Lee DJ, Lim WA . (1999). Cell 97: 471–480.

  • Ridley AJ, Hall A . (1992). Cell 70: 389–399.

  • Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A . (1992). Cell 70: 401–410.

  • Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, Sasaki M et al. (2003). Nat Cell Biol 5: 427–432.

  • Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV . (1997). Biochem Biophys Res Commun 236: 54–58.

  • Stahl S, Ittrich C, Marx-Stoelting P, Kohle C, Altug-Teber O, Riess O et al. (2005). Hepatology 42: 353–361.

  • Tsuboi Y, Ichida T, Sugitani S, Genda T, Inayoshi J, Takamura M et al. (2004). Liver Int 24: 432–436.

  • Vaudry D, Stork PJ, Lazarovici P, Eiden LE . (2002). Science 296: 1648–1649.

  • Volkman BF, Prehoda KE, Scott JA, Peterson FC, Lim WA . (2002). Cell 111: 565–576.

  • Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K et al. (2001). Nature 412: 647–651.

  • Yano H, Maruiwa M, Murakami T, Fukuda K, Ito Y, Sugihara S et al. (1988). Acta Pathol Jpn 38: 953–966.

  • Yoshida T, Ogata H, Kamio M, Joo A, Shiraishi H, Tokunaga Y et al. (2004). J Exp Med 199: 1701–1707.

  • Zaragoza C, Soria E, Lopez E, Browning D, Balbin M, Lopez-Otin C et al. (2002). Mol Pharmacol 62: 927–935.

  • Zhang D, Bar-Eli M, Meloche S, Brodt P . (2004). J Biol Chem 279: 19683–19690.

Download references

Acknowledgements

We thank Ms Masako Sinkawa for her excellent technical assistance and Ms Mieko Hatae and Ms Motoko Gotoh for manuscript preparation. This work was supported by the 21st Century COE Program for Medical Science of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Yoshida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshida, T., Hisamoto, T., Akiba, J. et al. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene 25, 6056–6066 (2006). https://doi.org/10.1038/sj.onc.1209635

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209635

Keywords

This article is cited by

Search

Quick links